Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study

Fig. 2

Pain in OA patients according to VAS (N = 51). Means (standard deviation) are used. To compare the VAS Scores between the SPMs group (N = 23) and placebo group (N = 28), the Mann–Whitney U test (basal) and the Student's t-test (weeks 4, 8, and 12) were used. * p-value < 0.05. SPMs: specialized pro-resolving lipid mediators; VAS: Visual Analogue Scale

Back to article page